| (11) | Number of the document | 4792 |
| (21) | Number of the application | a 2020 0034 |
| (22) | Filing date of the application | 2020.05.04 |
| | Date of filing the request for examination | (de fond) 04.05.2020 |
| (71) | Name(s) of applicant(s), code of the country | INSTITUTUL DE CHIMIE, MINISTERUL EDUCAŢIEI ŞI CERCETĂRII, MD; KATHOLIEKE UNIVERSITEIT LEUVEN, BE; UNIVERSITÄT BERN, CH; |
| (72) | Name(s) of inventor(s), code of the country | KULCITKI Veaceslav, MD; GIRBU Vladilena, MD; PRUTEANU Elena, MD; RENAUD Philippe, CH; DAELEMANS Dirk, BE; UNGUR Nicon, MD; |
| (73) | Name(s) of owner(s), code of the country | INSTITUTUL DE CHIMIE, MINISTERUL EDUCAŢIEI ŞI CERCETĂRII, MD; KATHOLIEKE UNIVERSITEIT LEUVEN, BE; UNIVERSITÄT BERN, CH; |
| (54) | Title of the invention | (16R)-Spiro[pyrrolidine-2´,16-ent-17-norkauran]-19-oic acid methyl ester with selective cytotoxic activity |
| (13) | Kind-of-document code | |
| (51) | International Patent Classification | C07D 209/96 (2006.01); C07C 61/125 (2006.01); A61K 31/015 (2006.01); A61K 31/403 (2006.01); A61P 35/00 (2006.01); |
| (19) | Country | MD |
| (41) | Date of publication of the application | 2021.11.30 |
| (45) | Date of publication of patent granting decision: | 2022.02.28 |
| (47) | Date of issuance of patent | 2022.09.30 |
| (74) | Patent attorney | JOVMIR Tudor, Str. Miorita nr. 5, bl. 2, ap. 19, MD-2028, Chişinău, Republica Moldova |
| | Substantive examiner(s) | LEVIŢCHI Svetlana |
| | Payment for maintenance up to the date | 2025.05.04 |